Tumor M2 pyruvate kinase--determination in breast cancer patients receiving trastuzumab therapy. [electronic resource]
Producer: 20030106Description: 223-8 p. digitalISSN:- 0304-3835
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- blood
- Breast Neoplasms -- drug therapy
- Female
- Humans
- Middle Aged
- Mucin-1 -- metabolism
- Neoplasm Staging
- Prognosis
- Pyruvate Kinase -- blood
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Retrospective Studies
- Trastuzumab
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.